US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

2  3  4  5    7    9  10  11  
Anti-CD6 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities ...  |  read more...
USD 1,250
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Protein (Sir2 Protein or Sirtuin) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical ...  |  read more...
USD 1,250
Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Codexis, Inc. (CDXS) - Financial and Strategic SWOT Analysis Review
7/19/2016 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 300
Covance Inc. - Strategic SWOT Analysis Review
7/19/2016 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Medigen Biotechnology Corporation (3176) - Financial and Strategic SWOT Analysis Review
7/19/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
7/19/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review
7/19/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
ImmunoGen, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes ImmunoGen, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and ...  |  read more...
USD 350
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016
6/1/2016 | published by: Current Partnering
... and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2010 to 2016. The report provides a detailed understanding ...  |  read more...
USD 2,995
Protein Electrophoresis and Western Analysis Life Science Dashboard™ Series 3 (NA & EU)
6/1/2016 | published by: Percepta Associates, Inc.
... detect the proteins of interest. With a wide variety of applications in proteomics, ranging from protein characterization to protein quantification and applications in other areas such as clinical diagnostics and verification of in vivo and ...  |  read more...
USD 6,500
Acorda Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Acorda Therapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of ...  |  read more...
USD 350
ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review
7/5/2016 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Lixte Biotechnology Holdings, Inc. (LIXT) - Financial and Strategic SWOT Analysis Review
7/5/2016 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Advaxis, Inc. (formerly Great Expectations & Associates, Inc.)'s contact information and business summary, tables, ...  |  read more...
USD 350
Albany Molecular Research, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes Albany Molecular Research, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a ...  |  read more...
USD 350
Global IR Spectroscopy Equipment Market Research Report 2021
7/1/2016 | published by: QYResearch Group
... definitions, classifications and applications. The IR spectroscopy market analysis is provided for the international market including development history, competitive landscape analysis, and major regions¡¯ development status. Secondly, this report also states supply and consumption figures ...  |  read more...
USD 2,900
United Therapeutics Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/30/2016 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. This report includes United Therapeutics Corporation's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of ...  |  read more...
USD 350
2  3  4  5    7    9  10  11